logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ESMO 2018 – Vaccine combined with adjuvant trastuzumab prolongs disease-free survival in triple-negative breast cancer

Preliminary results suggest vaccine allows TNBC patients to benefit from trastuzumab